{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for amphotericin root_Display\ Name in Display Name (approximate match)
Status:
Investigational
Source:
USAN:HIOXIFILCON B [USAN]
Source URL:
Class:
POLYMER
Status:
Other
Class:
POLYMER
Status:
Other
Class:
POLYMER
Status:
Other
Class:
POLYMER
Status:
Other
Class:
POLYMER
Status:
Other
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
NCT04560283: Phase 4 Interventional Completed Vagina; Anomaly
(2016)
Source URL:
First approved in 1990
Source:
Flor-Opal Sustained-Release Fluoride by Ultradent Products, Inc
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
M017
(2022)
Source URL:
First approved in 1989
Source:
M017
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
M020
(1980)
Source URL:
First approved in 1980
Source:
M020
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
ANDA074093
(1992)
Source URL:
First approved in 1976
Source:
NDA020353
Source URL:
Class:
POLYMER
![Structure of Petrafocon A-Hem-Larafilcon A [Component B (soft skirt)]](/img/002f2305-1bfd-4010-8fde-63069e7a873b.svg?size=200&context=yvfjbjzaio)
